Nedime Sahinoglu-Keskek Selected Research

Iris Diseases

1/2021

Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nedime Sahinoglu-Keskek Research Topics

Disease

1	Iris Diseases 01/2021
1	Hemorrhage 01/2021
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021
1	Retinal Neovascularization 01/2021
1	Birth Weight (Birth Weights) 01/2021
1	Keratoconjunctivitis 01/2019
1	Choroidal Effusions 01/2018
1	Glaucoma 01/2018
1	Glioma (Gliomas) 01/2018
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2018
1	Ganglion Cysts (Ganglion) 01/2018
1	Retinal Detachment (Retinal Detachments) 04/2015
1	Retinal Perforations 04/2015
1	Infections 04/2015
1	Vitreous Hemorrhage 04/2015
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 09/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Sepsis (Septicemia) 01/2013

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 01/2018 - 09/2014
1	Ranibizumab (Lucentis)FDA Link 01/2021
1	Povidone-Iodine (Betadine)FDA LinkGeneric 01/2019
1	Ophthalmic Solutions (Eye Drops)IBA 01/2018
1	Latanoprost (Xalatan)FDA Link 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2014
1	Intravitreal Injections 04/2015
1	Phototherapy (Light Therapy) 01/2013